ELECTROMED has had the honour to be chosen as one of the "Breakthrough ideas" that has contributed to the frist newsletter of the European Innovation Council dedicated to the COVID-19.
The partners in ELECTROMED are committed to contribute in the COVID-19 crisis with possible solutions both for diagnosis and possible vaccine developments.
The technology of ELECTROMED can be deployed for label free sensing for direct detection of viral RNA and immunity biomarkers, while the flexible synthesis of peptides could in the future be used for vaccince discovery.
